Literature DB >> 3056201

Treatment of Lyme borreliosis with emphasis on neurological disease.

B Sköldenberg1, G Stiernstedt, M Karlsson, B Wretlind, B Svenungsson.   

Abstract

We have studied 113 patients with neurologic Lyme borreliosis and meningitis who were treated with intravenous high-dose antibiotics (penicillin G, 12 g, mostly for 14 days in 47 patients; penicillin G, 9 g, mostly for 10 days in 58 patients; doxycycline, 200 mg, in 5 patients; and cefuroxime, 4.5-9 g, in 3 patients). Seventy percent of the patients had peripheral nerve symptoms and 13% had central nervous symptoms. Almost half of the patients were treated more than 4 weeks after the onset of symptoms and 15% of the patients had persisting or progressive symptoms between 4 and 11 months. There seemed to be clinical benefit as well as a decrease of spinal fluid pleocytosis and spinal proteins. No significant symptoms of Herxheimer reaction were demonstrated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056201     DOI: 10.1111/j.1749-6632.1988.tb31866.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.

Authors:  M Karlsson; S Hammers; I Nilsson-Ehle; A S Malmborg; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

2.  Unique expression of chronic Lyme disease and Jarisch-Herxheimer reaction to doxycycline therapy in a young adult.

Authors:  Chad Haney; Milap C Nahata
Journal:  BMJ Case Rep       Date:  2016-07-20

Review 3.  Childhood Lyme borreliosis in Europe.

Authors:  H I Huppertz
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

4.  Therapy of Lyme borreliosis in children.

Authors:  L Krbkova; G Stanek
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

5.  Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study.

Authors:  R R Müllegger; M M Millner; G Stanek; K D Spork
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.